Abstract：Objective To investigate the trends in mortality and life loss of gastric cancer in Wenzhou City, Zhejiang Province from 2014 to 2023, so as to provide the evidence for formulating the prevention and control strategy for gastric cancer. Methods The surveillance on causes of death data of permanent residents in Wenzhou City were collected through the Wenzhou Chronic Disease Monitoring and Management Information System from 2014 to 2023. The crude mortality of gastric cancer was calculated, and standardized by the data from the Sixth Chinese National Population Census in 2010. The life loss were measured using potential years of life lost (PYLL) and rate of potential years of life lost (PYLLR). The characteristics of mortality and life loss of gastric cancer in different genders and age groups were described. The trends in mortality and PYLLR of gastric cancer were analyzed using the average annual percent change (AAPC). Results Totally 17 080 deaths were reported due to gastric cancer in Wenzhou City from 2014 to 2023, accounting for 12.58% and ranking third in the order of malignant tumor deaths. The crude mortality of gastric cancer was 20.73/105, and the standardized mortality was 15.22/105, showing decreasing trends (AAPC=-3.311%, -6.470%, both P<0.05). The crude mortality of gastric cancer was 29.22/105 in men and 11.61/105 in women, with standardized mortality rates of 20.81/105 and 8.74/105 (both P<0.05). The crude mortality of gastric cancer appeared a tendency towards a rise with increasing age (P<0.05), reaching the highest rate of 225.88/105 in the group aged 80 to <85 years. The PYLL and PYLLR of gastric cancer were 107 607.50 person-years and 1.37‰. The PYLLR appeared a tendency towards a decline from 2014 to 2023, with AAPC of -6.667% (P<0.05). Conclusions The mortality and PYLLR of gastric cancer in Wenzhou City appeared a tendency towards a decline from 2014 to 2023. Men and the elderly populations were the key groups for the prevention and treatment of gastric cancer.
叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
YE Zhenmiao, FAN Lihui, JIANG Xuexia, ZHENG Yuhang, ZHANG Mohan, LUO Yongyuan, XIE Yimin, LI Huijun, JIN Xi. Trends in mortality and life loss of gastric cancer in Wenzhou City from 2014 to 2023. Preventive Medicine, 2025, 37(3): 267-271.
[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CACancer J Clin,2021,71(3):209-249. [2] 刘宗超,李哲轩,张阳,等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2021,7(2):1-13. LIU Z C,LI Z X,ZHANG Y,et al.Interpretation on the report of Global Cancer Statistics 2020[J].JMCM,2021,7(2):1-13.(in Chinese) [3] 曹毛毛,李贺,孙殿钦,等.2000—2019年中国胃癌流行病学趋势分析[J].中华消化外科杂志,2021,20(1):102-109. CAO M M,LI H,SUN D Q,et al.Epidemiological trend analysis of gastric cancer in China from 2000 to 2019[J].Chin J Dig Surg,2021,20(1):102-109.(in Chinese) [4] 倪建晓,吴文秀,苏依所,等.2013—2020年瓯海区居民恶性肿瘤死亡趋势及减寿分析[J].预防医学,2022,34(4):413-418. NI J X,WU W X,SU Y S,et al.Trends in mortality and life lost due to cancer in Ouhai District from 2013 to 2020[J].China Prev Med J,2022,34(4):413-418.(in Chinese) [5] 王永,包凯芳,王思嘉,等.2011—2022年宁波市胃癌发病和死亡趋势分析[J].预防医学,2023,35(7):557-562. WANG Y,BAO K F,WANG S J,et al.Trends in incidence and mortality of gastric cancer in Ningbo City from 2011 to 2022[J].China Prev Med J,2023,35(7):557-562.(in Chinese) [6] 季巧英,刘晓红,杜冬明,等.丽水市居民胃癌发病和死亡特征分析[J].预防医学,2019,31(11):1108-1111. JI Q Y,LIU X H,DU D M,et al.Incidence and mortality of gastric cancer in Lishui City[J].China Prev Med J,2019,31(11):1108-1111.(in Chinese) [7] 马霞,张军,周林,等.2021年山东省济南市胃癌发病和死亡流行特征及2014—2021年趋势分析[J].中国肿瘤,2024,33(6):478-485. MA X,ZHANG J,ZHOU L,et al.Incidence and mortality of gastric cancer in Jinan City of Shandong Province in 2021 and the trends from 2014 to 2021[J].China Cancer,2024,33(6):478-485.(in Chinese) [8] 国家消化系统疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟,中华医学会消化病学分会幽门螺杆菌学组,等.中国幽门螺杆菌根除与胃癌防控的专家共识意见(2019年,上海)[J].中华健康管理学杂志,2019,13(4):285-291. National Clinical Research Center for Digestive Diseases(Shanghai),National Early Gastrointestinal Cancer Prevention and Treatment Center Alliance,Helicobacter pylori Committee of Chinese Society of Gastroenterology,et al.Chinese consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer(2019,Shanghai)[J].Chin J Health Manag,2019,13(4):285-291.(in Chinese) [9] 杜君彦,潘杰,周晴接,等.2013—2020年浙江温州地区幽门螺杆菌耐药情况分析[J].中国全科医学,2023,26(7):825-829. DU J Y,PAN J,ZHOU Q J,et al.The Helicobacter Pylori antibiotic resistance in Wenzhou,Zhejiang from 2013 to 2020[J].Chin Gen Pract,2023,26(7):825-829.(in Chinese) [10] 陈永胜,朱健,王军,等.1972—2016年江苏省启东市胃癌死亡流行特征分析[J].中华肿瘤杂志,2022,44(1):99-103. CHEN Y S,ZHU J,WANG J,et al.Epidemic characteristics of stomach cancer mortality in Qidong during 1972-2016[J].Chin J Oncol,2022,44(1):99-103.(in Chinese) [11] 郑纲,张沛绮,陈茜,等.温州市鹿城区居民慢性病相关行为危险因素现况调查[J].中国农村卫生事业管理,2018,38(11):1447-1449. ZHENG G,ZHANG P Q,CHEN Q,et al.Risk factors of chronic disease behavior among residents in Lucheng District,Wenzhou City[J].Chin Rural Health Serv Administration,2018,38(11):1447-1449.(in Chinese) [12] 杨桂丽,陈镭,张晓红,等.温州市居民健康素养与吸烟行为调查[J].预防医学,2018,30(3):253-256. YANG G L,CHEN L,ZHANG X H,et al.Association between health literacy and smoking status among residents in Wenzhou City[J].China Prev Med J,2018,30(3):253-256.(in Chinese) [13] WANG X M,HUANG X,FU Z Q,et al.Biphasic ER-alpha36-mediated estrogen signaling regulates growth of gastric cancer cells[J].Int J Oncol,2014,45(6):2325-2330. [14] 赫捷,陈万青,李兆申,等.中国胃癌筛查与早诊早治指南(2022,北京)[J].中国肿瘤,2022,31(7):488-527. HE J,CHEN W Q,LI Z S,et al.China guideline for the screening,early detection and early treatment of gastric cancer(2022,Beijing)[J].China Cancer,2022,31(7):488-527.(in Chinese)
